Molecular characteristics of circulating tumor cells resemble the liver metastasis more closely than the primary tumor in metastatic colorectal cancer.
Author(s): Onstenk W, Sieuwerts AM, Mostert B, Lalmahomed Z, Bolt-de Vries JB, van Galen A, Smid M, Kraan J, Van M, de Weerd V, Ramírez-Moreno R, Biermann K, Verhoef C, Grünhagen DJ, IJzermans JN, Gratama JW, Martens JW, Foekens JA, Sleijfer S
Publication: Oncotarget, 2016, Vol. 7, Page 59058-59069
PubMed ID: 27340863 PubMed Review Paper? No
Purpose of Paper
This paper compared the gene expression profiles of circulating tumor cells (CTCs) isolated by CellSearch with those from case-matched formalin-fixed paraffin-embedded (FFPE) primary tumor and metastatic tissue specimens.
Conclusion of Paper
The CTC gene expression profile was concordant with the liver metastasis in more patients (74%) than the corresponding primary tumor specimen (57%). Levels of concordance were not affected by time of metastasis presentation (synchronous or metachronous), number of metastases, chemotherapy, or patient age or gender. Nine of the 25 genes examined were downregulated in CTCs compared to primary tumor and seven were also downregulated when compared to liver metastases.
Studies
-
Study Purpose
This study compared the gene expression profiles of CTCs isolated by CellSearch with those from case-matched FFPE primary tumor and metastatic tissue specimens. Peripheral blood (30 mL) was collected in CellSave and EDTA tubes from 23 patients with metastatic colorectal cancer just prior to liver surgery and processed within 24 h. Red blood cells were removed by a modified Ficoll density gradient and CTCs were isolated and enumerated using the CellSearch method. RNA was isolated from CTCs using the Qiagen AllPrep DNA/RNA Micro Kit. RNA was isolated using the High- Pure RNA Paraffin Kit from FFPE primary tumor and liver metastasis tissues with ≥30% tumor cells. Twenty-five CTC-specific genes were measured by real-time RT-qPCR and expression levels were normalized to three reference genes (GUSB, HMBS, and HPRT1).
Summary of Findings:
Primary tumor and metastasis gene expression profiles were concordant in 16/23 patients (70%). CTC gene expression profiles were concordant with the liver metastasis in 17/23 patients (74%) and with the primary tumor in 13/23 patients (57%). Gene expression profiles of CTCs more closely resembled those from the liver metastasis in 13 patients and the primary tumor in five patients, but reflected characteristics from both the primary tumor and the liver metastasis in three patients, and did not resemble either the primary tumor nor the liver metastasis in two patients. Levels of concordance were not affected by time of metastasis presentation (synchronous or metachronous), number of metastases, chemotherapy, or patient age or gender. Only FCGBP was significantly downregulated in the liver metastases compared to the primary tumor (P=0.004) and CDH1, CDH17, CDX1, CEACAM5, FABP1, FCGBP, IGFBP3, IGFBP4, and MAPT were significantly downregulated in CTCs (P=0.001-0.03). Similarly, CDH1, CDH17, CDX1, CEACAM5, FABP1, IGFBP3, and MAPT were significantly downregulated in CTCs compared to liver metastases (P=0.001-0.02).
Biospecimens
Preservative Types
- Formalin
- Other Preservative
Diagnoses:
- Neoplastic - Carcinoma
Platform:
Analyte Technology Platform RNA Real-time qRT-PCR Cell count/volume Fluorescent microscopy Pre-analytical Factors:
Classification Pre-analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Number of metastases
Synchronous metastasis presentation
Metachronous metastasis presentation
Chemotherapy
No chemotherapy
Preaquisition Patient age 68 ± 10 years
Real-time qRT-PCR Specific Targeted nucleic acid AGR2
AKR1C3
CDH1
CDH17
CDH5
CDX1
CEACAM5
COL4A1
CXCL1
FABP1
FCGBP
GPX2
IGFBP3
IGFBP4
IGFBP5
KRT19
KRT20
LAD1
MACROD1
MAPT
PRSS8
RARRES2
S100P
TRIM2
TSPAN8
GUSB
HMBS
HPRT1
Preaquisition Patient gender Female
Male
Biospecimen Acquisition Biospecimen location Primary colorectal tumor
Liver metastasis
Circulating tumor cell
